Does Rallies show 13F holders for ICCC?

Yes. Rallies tracks hedge fund and 13F ownership data for ICCC, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ICCC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ICCC. It does not provide personalized investment advice.

ICCC (Immucell Corp) Stock Analysis - Hedge Fund Holdings

Immucell Corp (ICCC) is a publicly traded Healthcare sector company. As of May 21, 2026, ICCC trades at $9.88 with a market cap of $89.65M and a P/E ratio of -140.91. ICCC moved -4.90% today. Year to date, ICCC is +63.31%; over the trailing twelve months it is +78.34%. Its 52-week range spans $3.38 to $10.25. Rallies surfaces ICCC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ICCC stock?

Hedge funds tracked by Rallies that own ICCC include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Immucell Corp.

ICCC Key Metrics

Key financial metrics for ICCC
Metric	Value
Price	$9.88
Market Cap	$89.65M
P/E Ratio	-140.91
EPS	$-0.07
Dividend Yield	0.00%
52-Week High	$10.25
52-Week Low	$3.38
Volume	0
Avg Volume	0
Revenue (TTM)	$29.93M
Net Income	$-545.40K
Gross Margin	42.59%

Top Hedge Funds Holding ICCC

Renaissance Technologies holds 136.99K shares of ICCC, changed -8.36% as of Dec 31, 2024.
Citadel Advisors holds 29.02K shares of ICCC, changed +22.21% as of Dec 31, 2024.

Latest ICCC News

ImmuCell reports $10.4M Q1 sales, net income up 34% to $1.9M — May 16, 2026
ImmuCell Q1 Sales Rise 28.4% to $10.4M, Tri-Shield® Up 38.5% — Apr 8, 2026
ImmuCell Corp Margin Rises to 41% as Net Loss Narrows to $1M — Mar 7, 2026
ImmuCell 2025 Sales Up 4.3% to $27.6M with $1.6M Operating Income — Mar 4, 2026
ImmuCell Q4 Sales Dip 1.6% to $7.6M, Takes $2.9M Re-Tain® Charge — Jan 9, 2026

Recent ICCC Insider Trades

te Boekhorst Paul Francis Olivier bought 2.43K (~$13.38K) on Dec 4, 2025.
te Boekhorst Paul Francis Olivier bought 3.60K (~$18.15K) on Dec 3, 2025.
te Boekhorst Paul Francis Olivier bought 2.56K (~$12.79K) on Dec 3, 2025.

ICCC Analyst Consensus

ICCC analyst coverage data. Average price target: $0.00.

Common questions about ICCC

Who owns ICCC stock?: Hedge funds tracked by Rallies that own ICCC include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Immucell Corp.
Does Rallies show 13F holders for ICCC?: Yes. Rallies tracks hedge fund and 13F ownership data for ICCC, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ICCC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ICCC. It does not provide personalized investment advice.